Virtu Financial’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31K | Sell |
40,048
-38,905
| -49% | -$32.8K | ﹤0.01% | 1352 |
|
|
2025
Q4 | $62K | Buy |
+78,953
| New | +$64.8K | ﹤0.01% | 1279 |
|
|
2025
Q3 | – | Sell |
-31,959
| Closed | -$162K | – | 2210 |
|
|
2025
Q2 | $162K | Buy |
+31,959
| New | +$126K | 0.01% | 961 |
|
|
2024
Q4 | – | Sell |
-29,017
| Closed | -$51K | – | 2178 |
|
|
2024
Q3 | $51K | Buy |
29,017
+1,051
| +4% | +$1.91K | ﹤0.01% | 1009 |
|
|
2024
Q2 | $44K | Buy |
+27,966
| New | +$48.7K | ﹤0.01% | 922 |
|
|
2024
Q1 | – | Sell |
-26,409
| Closed | -$37K | – | 2209 |
|
|
2023
Q4 | $37K | Buy |
26,409
+12,747
| +93% | +$16.4K | ﹤0.01% | 1225 |
|
|
2023
Q3 | $22K | Buy |
+13,662
| New | +$25.3K | ﹤0.01% | 1001 |
|
|
2022
Q3 | – | Sell |
-12,845
| Closed | -$36K | – | 2316 |
|
|
2022
Q2 | $36K | Sell |
12,845
-281
| -2% | -$1.02K | ﹤0.01% | 1207 |
|
|
2022
Q1 | $70K | Buy |
+13,126
| New | +$74.4K | 0.01% | 1052 |
|
|
2021
Q4 | – | Sell |
-143,677
| Closed | -$1.3M | – | 2259 |
|
|
2021
Q3 | $1.3M | Buy |
+143,677
| New | +$859K | 0.11% | 168 |
|
|
2021
Q1 | – | Sell |
-27,736
| Closed | -$108K | – | 2109 |
|
|
2020
Q4 | $108K | Buy |
+27,736
| New | +$101K | 0.01% | 1036 |
|
|
2019
Q4 | $47K | Buy |
+11,183
| New | +$43.2K | ﹤0.01% | 1212 |
|
|
2019
Q2 | – | Sell |
-2,962
| Closed | -$23K | – | 1944 |
|
|
2019
Q1 | $23K | Buy |
+2,962
| New | +$21.1K | ﹤0.01% | 1276 |
|
|
2018
Q3 | – | Sell |
-761
| Closed | -$10K | – | 2311 |
|
|
2018
Q2 | $10K | Buy |
+761
| New | +$18K | ﹤0.01% | 1906 |
|
Other funds holding ATYR
VCM
GCP
